SCHEMBL3210019

SCHEMBL3210019

CCc1ccc(C2(c3ccccc3)c3ccccc3N(c3ccccc3)c3ccccc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.40
GPR55 Q9Y2T6 1/20 0.40
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
ALDH1A1 P00352 1/20 0.39
THPO P40225 1/20 0.39
TP53 P04637 1/20 0.38
MAPK1 P28482 1/20 0.37
ALOX15B O15296 1/20 0.37
GAA P10253 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MGLL Q99685 1/20 0.37
ELANE P08246 4/20 0.36
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
OPRL1 P41146 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20383358 0.85 ALDH1A1 (0.39) CNR1GPR55CYP1A2CYP3A4CYP2D6
SCHEMBL29833177 0.85 ALDH1A1 (0.41) CNR1GPR55CYP1A2CYP3A4CYP2D6
SCHEMBL2754763 0.85 ALDH1A1 (0.41) CNR1GPR55CYP1A2CYP3A4CYP2D6
SCHEMBL20229579 0.84 ALDH1A1 (0.36) CNR1GPR55CYP1A2CYP3A4CYP2D6
SCHEMBL15030649 0.82 ALDH1A1 (0.39) CNR1GPR55CYP1A2CYP3A4CYP2D6
SCHEMBL13231436 0.82 ALDH1A1 (0.37) CNR1GPR55CYP1A2CYP3A4CYP2D6
SCHEMBL20383369 0.81 PGR (0.40) CNR1GPR55CYP1A2CYP3A4CYP2D6
SCHEMBL20383356 0.81 FAAH (0.38) CNR1GPR55CYP1A2CYP3A4CYP2D6
SCHEMBL2754768 0.81 PGR (0.39) CNR1GPR55CYP1A2CYP3A4CYP2D6
SCHEMBL20383372 0.80 LMNA (0.40) CNR1GPR55CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120001537-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2012-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120001537-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME OR10J3, ORC3, PIEZO1 CNR1 2070/4885GPR55 4073/4885CYP1A2 2391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.